The role of receptor tyrosine kinase inhibition in treating gastrointestinal malignancy

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.4, 2003-04, pp. : 577-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of the Non-Receptor Tyrosine Kinase Fes in Cancer

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2913-2920

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinase Kit and Gastrointestinal Stromal Tumours: An Overview

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2893-2903

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells

Current Medicinal Chemistry, Vol. 23, Iss. 15, 2016-05 ,pp. : 1496-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists

By Rossowski W.J. Cheng B.-L. Taylor J.E. Datta R. Coy D.H.

European Journal of Pharmacology, Vol. 438, Iss. 3, 2002-03 ,pp. : 159-170

Elsevier

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor Subfamily: Role as Anticancer Agents

By Noonberg S.B. Benz C.C.

Drugs, Vol. 59, Iss. 4, 2000-04 ,pp. : 753-767

Adis International

Access to resources Recommend Favorite